" /> Factor VIII von Willebrand factor.ristocetin cofactor given:ACnc:Pt:Dose:Qn:vWF dosing - CISMeF





Preferred Label : Factor VIII von Willebrand factor.ristocetin cofactor given:ACnc:Pt:Dose:Qn:vWF dosing;

LOINC status : ACTIVE;

LOINC display name : Factor VIII von Willebrand factor (vWf) ristocetin cofactor given vWF dosing Qn (Dose);

LOINC long common name : Factor VIII von Willebrand factor (vWf) ristocetin cofactor given [Units/volume] by vWF dosing;

LOINC short name : FVIII vWf:RCo Gvn Dose vWF dose-aCnc;

LOINC description : The amount of factor VIII (FVIII) and Von Willebrand factor.ristocetin cofactor (vWF:RCo) complex given based on the IU of vWF:RCo dosing for patients with Von Willebrand disease. For dosing based on Factor VIII for patients with hemophilia, see [LOINC: 77726-8]. This term was created for, but not limited in use to, Humate-P. According to the package insert provided by the submitter, Humate-P is an antihemophilic factor/von Willebrand factor complex approved to treat and prevent bleeding in adult patients with hemophilia A and also to treat spontaneous or trauma-induced bleeding episodes as well as prevent excessive bleeding during and after surgery in adults and children with von Willebrand disease (VWD).;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
14/06/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.